(Q46929643)

English

Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.

scientific article published on 20 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Pierre I Karakiewicz

16

object named as

Pierre I Karakiewicz

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Shahrokh Shariat

2

object named as

Shahrokh F Shariat

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

6

object named as

Wassim Kassouf

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Vincenzo Ficarra

17

object named as

Vincenzo Ficarra

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

10

object named as

Shiro Baba

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Hans-Martin Fritsche

3

object named as

Hans-Martin Fritsche

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

14

object named as

Armin Pycha

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Juan Ignacio Martínez-Salamanca

12

object named as

Juan I Martínez-Salamanca

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

18

object named as

Giacomo Novara

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Guido Martignoni

7

object named as

Guido Martignoni

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Stefan Tritschler

9

object named as

Stefan Tritschler

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

author name string

Amit Gupta

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Kazumasa Matsumoto

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Thomas J Walton

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Patrick J Bastian

11

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Christian Seitz

13

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Maximilian Burger

15

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

publication date

20 January 2011

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

World Journal of Urology

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

29

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

487-494

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

https://scigraph.springernature.com/pub.10.1007/s00345-011-0645-8

0 references

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guérin therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0645-8

21 January 2018

Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review

1 reference

https://pubmed.ncbi.nlm.nih.gov/21249372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21249372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21249372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21249372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21249372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21249372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21249372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21249372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Location of the Primary Tumor is Not an Independent Predictor of Cancer Specific Mortality in Patients With Upper Urinary Tract Urothelial Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21249372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00345-011-0645-8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/21249372

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46929643&oldid=1742947706"